Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Using neurohormones to control keratin can lead to new skin disease treatments.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Neurohormones help control skin health and could treat skin disorders.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Melatonin treatment started hair growth in goats and affected their hormone levels.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Ficus carica extract improved fertility in rats and may help with certain health conditions.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Hormonal imbalances are important in the development of male pattern baldness.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Human scalp hair follicles can produce and respond to several hormones, affecting hair growth and pigmentation.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

Different drugs are used to manage breeding, prevent or end pregnancy, and treat reproductive issues in dogs and cats.

Doctors vary in how they initially test for PCOS, but most agree on using oral contraceptives and lifestyle changes as first treatments.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.